AS
DXCM icon

AM Squared’s DexCom DXCM Stock Holding History

AM Squared’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$422K Buy
+6,300
New +$517K 0.93% 10

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AM Squared's DXCM Position: Q3 2024 in Review

AM Squared opened a new position in DexCom (DXCM) in Q3 2024: 6,300 shares worth $422K. The stake represents 0.93% of the portfolio and ranks #10 among its holdings.

890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • AM Squared held 6,300 shares of DexCom worth $422K as of Q3 2024.
  • DexCom was a new AM Squared position in Q3 2024.
  • DexCom made up 0.93% of AM Squared's portfolio in Q3 2024, its #10 holding.
  • 890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on AM Squared's 13F filing for Q3 2024, filed 7 Nov 2024.